KaloBios (KBIO) Pharma Stock Rockets +65 Percent after CEO Shkreli Stops Lending Shares

Shares of KaloBios Pharmaceutical Inc. (KBIO) were trading up +17.17 or +64.48 percent to $43.80 per share in Friday's premarket after a Twitter comment by KaloBios Chief Executive, Martin Shkreli, in which he stated that he would not lend any more of his KaloBios stock for people looking to sell it short. KaloBios stock was ... READ MORE Read the rest of KaloBios (KBIO) Pharma Stock Rockets +65 Percent after CEO Shkreli Stops Lending Shares at InvestorGuide.com .